Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

REPL

Replimune Group Inc

May 29 • 04:00PM ET

8.69

+4.01 85.68 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: CCCC CHRS ZNTL ALLO ALEC CLLS ELDN IMRX LENZ GLSI

| Held by: XBI IWM VTI IWN IBB VXF SCHA VTWO IWC DFAS

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-3.58	Insider Own	7.68%	Shs Outstand	79.63M	Perf Week	66.48%
Market Cap	717.56M	Forward P/E	-	EPS next Y	-1.63	Insider Trans	-1.75%	Shs Float	76.23M	Perf Month	265.13%
Enterprise Value	524.77M	PEG	-	EPS next Q	-0.65	Inst Own	102.43%	Short Float	31.03%	Perf Quarter	13.59%
Income	-314.85M	P/S	-	EPS this Y	0.77%	Inst Trans	-6.02%	Short Ratio	3.82	Perf Half Y	-8.81%
Sales	0.00M	P/B	3.29	EPS next Y	46.40%	ROA	-67.19%	Short Interest	23.66M	Perf YTD	-10.60%
Book/sh	2.64	P/C	2.67	EPS next 5Y	33.42%	ROE	-90.88%	52W High	13.24 -34.37%	Perf Year	-7.26%
Cash/sh	3.26	P/FCF	-	EPS past 3/5Y	-10.73% -14.85%	ROIC	-111.33%	52W Low	1.50 479.33%	Perf 3Y	-55.41%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	10.15% 15.23%	Perf 5Y	-77.70%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-13.96%	Oper. Margin	-	ATR (14)	0.83	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	5.60	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	75.79	Recom	3.50
Dividend Gr. 3/5Y	- -	Current Ratio	5.60	EPS Q/Q	3.16%	SMA20	92.68%	Beta	0.38	Target Price	2.20
Payout	-	Debt/Eq	0.36	Sales Q/Q	-	SMA50	84.06%	Rel Volume	8.25	Prev Close	4.68
Employees	479	LT Debt/Eq	0.34	Earnings	Feb 03 BMO	SMA200	27.99%	Avg Volume	6.19M	Price	8.69
IPO	Jul 20, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.89% 0.00%	Trades		Volume	51,033,052	Change	85.68%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)